PI3-Kinase and PTEN at the Interface of Cell Growth, Vesicular Trafficking and Disease Scientific Organizers: Bart Vanhaesebroeck, Volker Haucke and Lori Friedman Date: May 03 - 07, 2020 Location: Herrenhausen Palace, Hannover, Germany The Phosphoinositide 3-Kinase (PI3K) signaling pathway is a main regulator in cell growth, metabolism, and survival and Phosphatase and TENsin homolog (PTEN) is a tumor suppressor gene. This conference integrates three decades of research and development in the PI3K/PTEN field and its progression towards the understanding and treatment of human disease. The discovery of rare human disorders arising from deregulation of the PI3K/PTEN pathway is providing important insights into the organismal biology of this pathway, as well as reviving interest in the repurposing of PI3K pathway inhibitors that were originally under development as anti-cancer agents. In addition, improved strategies to effectively use PI3K inhibitors in cancer are progressing through the clinic, with exciting new opportunities to use PI3K inhibitors in cancer immunotherapy treatment. This conference will cover the mechanism of action of the phosphoinositide lipids, their turnover and their downstream effectors, especially in relation to the class II and III PI3K isoforms, whose cellular and organismal functions are gradually being uncovered. Furthermore, the program will emphasize the emerging evidence for a critical role of the PI3K/PTEN pathway in neuronal biology, immunology and autophagy. This conference brings together basic scientists, drug developers and clinicians under one venue to discuss new paradigms in the field. Thus, this conference will catalyze information exchange and spark collaborations that will foster further scientific progress toward the improvement of human health. Global Health Travel Award Deadline: December 23 2019 detailsScholarship Deadline: January 7 2020 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
ORIC Pharmaceuticals
Keystone Symposia thanks the Volkswagen Foundation for hosting this conference:  |